Nearly nine-in-ten voters (86%) in New Jersey’s 5th district think prescription drug prices in the U.S. are too high, and 75% want to give Medicare the authority to negotiate lower prices, according to a Public Policy Polling survey released on Tuesday.
The poll was conducted by Protect Our Care, an advocacy group created to protect the Affordable Care Act.
The poll suggests that 40% of voters would be less likely to vote to re-elect Rep. Josh Gottheimer (D-Wyckoff) next year if he opposes legislation empowering the federal government to negotiate pricing on prescription drugs.
“Congressman Josh Gottheimer risks losing support from voters of all political affiliations if he opposes allowing Medicare to have the power to negotiate for lower drug prices,” said pollster Minami Yoshizawa.
Among Democrats, 50% say they’d be less likely to back Gottheimer if he opposes the plan.
Three-quarters of voters (75%) in the 5th support a bill sponsored by House Energy & Commerce Chairman Frank Pallone, Jr. (D-Long Branch) to authorize Medicare to negotiate a better deal on drug costs, while 12% oppose it.
Support for the proposal is 90%-4% among Democrats, and 73%-15% among Republicans, according to the poll.
President Joe Biden has job approvals of 45%-49% in the 5th district. Biden is upside-down among independents, 35%-59%.
Biden carried the 5th by six points in 2020.
Still, in the North Jersey district, 44% of voters say they trust Biden and Democrats on the issue of drug pricing; 39% say they trust Republicans more.
According to the poll, 62% of voters in the Bergen-Passaic-Sussex-Warren district view pharmaceutical and drug companies unfavorably, while just 16% view them favorably.
Public Policy Polling surveyed 593 New Jersey 5th district voters from August 25-26, 2021. The margin of error is +/- 4%.